Renal Disease in Primary Sjögren’s Syndrome

被引:0
作者
Oshorenua Aiyegbusi
Laura McGregor
Lucy McGeoch
David Kipgen
Colin C. Geddes
Kathryn I. Stevens
机构
[1] Queen Elizabeth University Teaching Hospital,Glasgow Renal and Transplant Unit
[2] Glasgow Royal Infirmary,Pathology Department
[3] Queen Elizabeth University Teaching Hospital,undefined
来源
Rheumatology and Therapy | 2021年 / 8卷
关键词
Glomerulonephritis; Kidney disease; Sjögren’s syndrome; Tubular dysfunction; Tubulointerstitial nephritis;
D O I
暂无
中图分类号
学科分类号
摘要
Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disorder characterised by lymphocytic infiltration of the exocrine glands, predominantly the salivary and lacrimal glands, leading to sicca symptoms. Patients may have extraglandular disease involving multiple organs, including the kidneys. 5% of patients with pSS can have renal involvement. Kidney disease in pSS presents a diagnostic challenge, as clinical symptoms are often insidious and can precede sicca symptoms. pSS affects the kidney through lymphocytic infiltration of renal tubules or immune complex deposition, leading to an array of clinical features. Tubulointerstitial nephritis is the most common histological pattern of kidney disease. Other tubular injuries include renal tubular acidosis with hypokalaemia, Fanconi’s syndrome and diabetes insipidus. Glomerular disease is less common and typically involves an immune complex-mediated process. Optimal treatment for kidney diseases in pSS is not established, and treatment is guided by the pattern of disease. For tubulointerstitial nephritis, management involves electrolyte imbalance correction and the use of immunosuppression, including steroids. Treatment of glomerular disease is targeted to the histological pattern, and often requires a combination of immunosuppressive agents. The risk of end-stage kidney disease is low. Nevertheless, patients with pSS and kidney disease have significantly reduced quality of life.
引用
收藏
页码:63 / 80
页数:17
相关论文
共 257 条
[21]  
Alexander EL(1991)Primary Sjogren’s syndrome associated with Bartter’s syndrome Clin Exper Rheumatol 9 210-212
[22]  
Carsons SE(1997)Hypokalaemic alkalosis, acquired Gitelman’s and Bartter’s syndrome in chronic sialoadenitis Br J Rheumatol 36 1125-1128
[23]  
François H(2010)Case review of sarcoidosis resembling Sjogren’s syndrome J Clin Med Res 2 284-288
[24]  
Mariette X(2009)A syndrome resembling Bartter’s syndrome in sarcoidosis Nephrol Dial Transplant 24 667-669
[25]  
Bossini N(2016)Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment BMC Musculoskelet Disord 17 2-1177
[26]  
Savoldi S(2009)Systemic and local interleukin-17 and linked cytokines associated with Sjögren’s syndrome immunopathogenesis Am J Pathol 175 1167-340
[27]  
Franceschini F(1988)Immunohistochemical identification of infiltrating mononuclear cells in tubulointerstitial nephritis associated with Sjogren’s syndrome Clin Nephrol 30 335-205
[28]  
Mombelloni S(1998)Cryoglobulinemia in primary Sjogren’s syndrome: prevalence and clinical characteristics in a series of 115 patients Semin Arthritis Rheum 28 200-175
[29]  
Baronio M(1997)Hepatitis C virus infection in ‘primary’ Sjogren’s syndrome: prevalence and clinical significance in a series of 90 patients Ann Rheum Dis 56 173-750
[30]  
Cavazzana I(2015)ANCA-associated vasculitis in patients with primary Sjögren’s syndrome: detailed analysis of 7 new cases and systematic literature review Autoimmun Rev 14 742-1192